Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study (Q33163524)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study |
scientific article |
Statements
1 reference
Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study (English)
1 reference
Joseph M Connors
1 reference
Michelle Fanale
1 reference
Anas Younes
1 reference
Steven I Park
1 reference
Megan M O'Meara
1 reference
Naomi N Hunder
1 reference
Dirk Huebner
1 reference
Stephen M Ansell
1 reference
15 November 2013
1 reference
1 reference
14
1 reference
13
1 reference
1348-1356
1 reference
Identifiers
1 reference
1 reference